Effect of rituximab on immunoglobulin levels in pediatric multiple sclerosis patients

被引：0
|
作者：
Mehta, N. [1 ]
Balasa, A. [2 ]
Shukla, N. [1 ]
Fisher, K. [1 ]
Lotze, T. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] West Virginia Univ, Morgantown, WV 26506 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1076
引用
收藏
页码：627 / 628
页数：2
相关论文
共 50 条
  • [41] Effect of Rituximab on Expanded Disability Status Scale and Relapse Rate in Multiple Sclerosis Patients
    Mehrdokht Mazdeh
    Mohammad Khamseh
    Mohammad Taheri
    Soudeh Ghafouri-Fard
    Journal of Molecular Neuroscience, 2020, 70 : 1165 - 1168
  • [42] Effect of Rituximab on Expanded Disability Status Scale and Relapse Rate in Multiple Sclerosis Patients
    Mazdeh, Mehrdokht
    Khamseh, Mohammad
    Taheri, Mohammad
    Ghafouri-Fard, Soudeh
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2020, 70 (08) : 1165 - 1168
  • [43] RITUXIMAB TREATMENT AND IMMUNOGLOBULIN LEVELS MONITORING
    Kasavkar, G.
    Kamath, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1188 - 1189
  • [44] Impact of Ocrelizumab on Immunoglobulin Levels and Infection Incidence: Navigating Treatment Adjustments in Multiple Sclerosis Patients
    Turkok, Cansu Gulcihan
    Yadi, Feyzullah
    Tezer, Damla Cetinkaya
    Dogan, Ipek Gungor
    Demir, Serkan
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1022 - 1023
  • [45] Intravenous immunoglobulin treatment in multiple sclerosis - Effect on relapses
    Achiron, A
    Gabbay, U
    Gilad, R
    Hassin-Baer, S
    Barak, Y
    Gornish, M
    Elizur, A
    Goldhammer, Y
    Sarova-Pinhas, I
    NEUROLOGY, 1998, 50 (02) : 398 - 402
  • [46] Rituximab treatment for multiple sclerosis
    Ineichen, Benjamin V.
    Moridi, Thomas
    Granberg, Tobias
    Piehl, Fredrik
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (02) : 137 - 152
  • [47] Rituximab, multiple sclerosis and pregnancy
    Fink, K.
    Gorczyca, A.
    Smith, J.
    Piehl, F.
    Langer-Gould, A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 173 - 174
  • [48] Effect of fingolimod treatment on circulating miRNA levels in patients with multiple sclerosis
    Fenoglio, C.
    Ridolfi, E.
    De Riz, M.
    Pietroboni, A.
    Calvi, A.
    Maltese, V.
    Serpente, M.
    Villa, C.
    Bonsi, R.
    Barone, C.
    Cioffi, S.
    Frigerio, F.
    Turrini, R.
    Galimberti, D.
    Scarpini, E.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 544 - 545
  • [49] The efficacy of ocrelizumab versus rituximab in treating patients with multiple sclerosis
    Shalaby, Nevin
    Abdul-Rahman, Ahmed
    Hegazy, Mohamed
    Merghany, Nahla
    Mounir, Nesma
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 600 - 601
  • [50] A retrospective observational study of rituximab in multiple sclerosis patients in Cyprus
    Leonidou, E.
    Pantzaris, M.
    Kleopa, K.
    Kyriakides, T.
    Loizidou, M.
    Christou, Y. P.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 912 - 913
12345